A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 3, 2002, Pages 238-243

  Kim, Tae You ^a   Yang, Sung Hyun ^a   Lee, Se Hoon ^a   Park, Young Seok ^a   Im, Yung Hyuck ^a   Kang, Won Ki ^a   Ha, Sung Hwan ^a   Park, Chan Il ^a   Heo, Dae Seog ^a   Bang, Yung Jue ^a   Kim, Noe Kyeong ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Chemotherapy; Non small cell lung cancer, advanced; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HIGH RISK POPULATION; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0036276942     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200206000-00007     Document Type: Article

References (35)

1. Cancer statistics, 1997
2. Chemotherapy of lung cancer
3. A new international staging system for lung cancer
4. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy
5. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer
6. Impact of tumor control on survival in carcinoma of the lung treated with irradiation
7. Non-small cell lung cancer
8. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer
9. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase 11 Southwest Oncology Group study
10. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report. CHART Steering Committee
11. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: Results of a North Central Cancer Treatment Group Phase III Study
12. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer
13. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
14. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
15. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer
16. Neoadjuvant cisplatin plus vinblastine chemotherapy in locally advanced non-small cell lung cancer
17. Treatment of stage III non-small cell lung cancer with thoracic radiation therapy and simultaneous platinum chemotherapy
18. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol
19. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis
20. Reporting results of cancer treatment
21. The effectiveness of adjustment by subclassification in removing bias in observational studies
22. Nonparametric estimation from incomplete observations
23. Evaluation of survival data and two new rank order statistics arising in its consideration
24. A multivariate analysis of the risk of coronary heart disease in Framingham
25. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
26. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
27. Clinical practice guidelines for the treatment of unresectable non- small-cell lung cancer (Adopted on May 16, 1997 by the American Society of Clinical Oncology)
28. Combined-modality therapy of locally advanced non-small-cell lung cancer
29. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung
30. Clinical factors and prognosis in non-small cell lung cancer
31. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
32. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
33. Combined modality therapy for unresectable stage III non-small cell lung cancer: New chemotherapy combinations
34. Role of multimodality treatment for lung cancer
35. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies